In adults with VTE who received anticoagulants for ≥3 mo, VTE-PREDICT predicted recurrence and bleeding at up to 5 y.
Where this comes from
- Record sourced from PubMed, PMID 37126813.
- Also identified by DOI 10.7326/J23-0021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
de Winter MA, Büller HR, Carrier M, et al; VTE-PREDICT study group. <b>Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.</b> Eur Heart J. 2023;44:1231-1244. 36648242.
Medical subject headings
- Anticoagulants
- Venous Thromboembolism